Table 5.
Dataset | Number of Compounds |
Percentage of dataset |
|||||
---|---|---|---|---|---|---|---|
Carboxylate | Heterocyclic nitrogen |
Hydrox- amate |
Phenol | Sulfonamide | Others | ||
Drugs | 3766 | 16.8 | 3.7 | 0.3 | 8.3 | 3.3 | 6.5 |
| |||||||
Aspartyl proteases | 4300 | 4.2 | 0.4 | 0.1 | 12.5 | 8.3 | 10.2 |
Cysteine proteases | 2503 | 13.3 | 2.7 | 0.5 | 1.7 | 3.5 | 3.2 |
GPCR amines | 20712 | 1.2 | 1.2 | 0.1 | 6.3 | 3.5 | 0.8 |
GPCR cannabinoid | 1510 | 0.3 | 0.4 | 0.1 | 13.6 | 0.1 | 2.7 |
GPCR nucleotide | 5228 | 2.1 | 16.3 | 0.1 | 1.5 | 0.2 | 15.6 |
GPCR class A other | 1972 | 3.2 | 3.5 | 0.8 | 4.9 | 1.3 | 4.6 |
GPCR peptide | 19602 | 19.4 | 1.5 | 0.1 | 10.9 | 6.8 | 7.3 |
GPCR prostaglandin | 1399 | 83.8 | 0.1 | 0.1 | 4.0 | 9.7 | 2.6 |
GPCR class B | 1391 | 3.5 | 0.0 | 0.0 | 8.6 | 0.0 | 3.2 |
GPCR class C | 1093 | 27.5 | 1.4 | 0.0 | 4.5 | 0.2 | 14.0 |
Integrins | 3300 | 91.8 | 1.0 | 0.0 | 3.8 | 3.5 | 7.7 |
Ligand-gated ion channel |
7357 | 9.1 | 7.2 | 0.1 | 7.8 | 0.5 | 4.4 |
Voltage-gated ion channel |
2761 | 3.5 | 2.9 | 0.0 | 2.1 | 1.6 | 3.0 |
Ion channel - other | 1263 | 6.8 | 1.8 | 0.4 | 15.6 | 8.0 | 9.5 |
Tyrosine kinases | 4229 | 2.8 | 3.9 | 1.6 | 7.1 | 0.2 | 9.6 |
Kinases – non tyrosine |
5635 | 2.6 | 16.9 | 0.4 | 7.2 | 0.9 | 4.7 |
Metalloproteases | 2024 | 35.7 | 0.9 | 56.8 | 4.5 | 5.8 | 15.3 |
Nuclear receptors | 6571 | 28.9 | 3.1 | 0.0 | 29.2 | 0.9 | 2.2 |
Oxido reductases | 5744 | 23.7 | 4.0 | 0.1 | 4.5 | 0.2 | 5.3 |
Oxygenases | 3890 | 16.5 | 0.6 | 7.2 | 7.1 | 3.5 | 1.2 |
Phosphodiesterases | 2555 | 4.9 | 8.9 | 3.1 | 2.2 | 0.4 | 8.8 |
Serine proteases | 5793 | 13.2 | 1.5 | 0.1 | 6.4 | 6.4 | 9.1 |
Transporters | 5240 | 4.7 | 0.0 | 0.0 | 1.8 | 0.1 | 1.0 |
Unknown targets | 22298 | 14.4 | 6.7 | 1.2 | 8.7 | 1.7 | 7.1 |
| |||||||
Vendors – drug-like clean |
6676776 | 2.4 | 2.6 | 0.0 | 1.8 | 4.5 | 5.6 |
Vendors – clean leads |
1716660 | 3.3 | 2.7 | 0.0 | 1.9 | 3.2 | 5.0 |
| |||||||
‘Natural’ products | 89425 | 13.8 | 2.8 | 0.0 | 8.4 | 0.7 | 3.4 |
Values are calculated by dividing the number of times the functional group is encountered by the total number of compounds and expressed as a percentage.